RNS Number : 9319R
Cellular Goods PLC
01 November 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

01 November 2023

 

Cellular Goods plc

 

("Cellular Goods" or "The Company")

 

Cellular Goods' products available for purchase in France and Germany

 

Cellular Goods (LSE: CBX), a UK based company pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions, is pleased to announce that products in its 'Look Better' skincare range are now available to purchase for the first time in France and Germany.

 

Cellular Goods has opened sales from its ecommerce website for shipping to France and Germany. The Company's products, including the best-selling Rejuvenating Face Serum, Rejuvenating Night Cream and Nourishing Face Oil which are all powered by the company's hero breakthrough anti-inflammatory CBG, are now available for shipping to France and Germany. The company's Rejuvenating Face Serum has been shown to visibly reverse the signs of skin ageing as effectively as retinol and vitamin C without the associated dryness and irritation.

 

Other products available for shipping to France and Germany include the Company's SPF25 Rejuvenating Day Cream, Rejuvenating Day Mousse and Calming Cannabinoid After Shaving Moisturiser, as well as 'mini' sizes, which are designed to be compact and convenient for travel, and gift sets.

 

All products are available for shipping to French and German consumers via the Company's ecommerce website, www.cellular-goods.com.

 

Darcy Taylor, Interim CEO, commented: "As we begin building momentum for the peak Christmas shopping period, Cellular Goods continues its focus on increasing global access to our 'Look Better' skincare range. We are pleased to have now opened our ecommerce site to our French and German customers, and we want to continue expanding our distribution of our breakthrough anti-inflammatory CBG powered products to deliver incremental revenue growth in CBG friendly markets."

 

For further information please contact:

 

Cellular Goods


Darcy Taylor

Chairman and Interim CEO

via FSCF +44 7572 873 300

First Sentinel Corporate Finance (FSCF)


Investor Relations

Rebecca Noonan

IR@cellular-goods.com

Media Relations

Rebecca Noonan

Media@cellular-goods.com

Corporate Broker & Advisor

Brian Stockbridge

 

+44 7572 873 300

 

 

+44 7572 873 300

 

 

+44 7876 888 011

Novum Securities

 

Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

 

About Cellular Goods PLC:

Cellular Goods is pioneering the use of lab-based and biosynthetic production methods for wellness and sustainability solutions. The Company launched with a focus on efficacy led and science-backed products utilising biosynthetics, and now employs its expertise across two verticals: premium next-generation cannabinoid skincare products, and carbon sequestration-as-a-service through its wholly owned business division, King Tide Carbon, which utilises biosynthetic algae and seaweed to provide scalable carbon removal. The Company is incorporated in the UK and listed on the Main Market of the London Stock Exchange. For more information, visit www.cellular-goods.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCWPGGWUUPWGMG